“…This is important from the perspective of viremia (CMV, BK virus) associated with the allograft as part of adaptive immunity. HLA-G expressed on the allograft interacts with ILT2, ILT4 and KIR2DL4 receptors on NK and T cells, leading to the inhibition of cytotoxicity and possibly towards graft acceptance [29,45]. Similarly, HLA-F will interact with ILT2 and ILT4 receptors [29,54] leading to the inhibition of cytotoxicity and graft acceptance; however, it remains to be elucidated whether allograft-associated vascular and endothelial cells, infiltrating leukocytes, can express HLA-F on their surface.…”